A disintegrin and metallproteinase 15 knockout decreases migration of fibroblast-like synoviocytes and inflammation in rheumatoid arthritis Retraction in /10.3892/mmr.2024.13165

Gao,Jinliang; Zheng,Wei; Wang,Liming; Song,Bailin

doi:10.3892/mmr.2015.3302

A disintegrin and metallproteinase 15 knockout decreases migration of fibroblast-like synoviocytes and inflammation in rheumatoid arthritis

Retraction in: /10.3892/mmr.2024.13165

Authors:
- Jinliang Gao
- Wei Zheng
- Liming Wang
- Bailin Song
View Affiliations

Affiliations: Department of Rheumatism, The Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China, Department of Ophthalmology, The Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China, Department of Otolaryngology, The Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China, Department of Massage, The Affiliated Hospital, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China
Published online on: February 4, 2015 https://doi.org/10.3892/mmr.2015.3302
Pages: 4389-4396

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to determine whether the expression of A disintegrin and metallproteinase 15 (ADAM15) affected the inflammatory conditions and cell migration in human fibroblast‑like synoviocytes (FLSs) in a rat model of rheumatoid arthritis (RA). The expression of ADAM15 in FLSs stimulated with lipopolysaccharide (LPS) was confirmed by reverse transcription‑quantitative polymerase chain reaction and western blot analysis. The effects of small interfering RNA targeting ADAM15 (siADAM5) on pro‑inflammatory cytokines and chemokines were assessed using an enzyme‑linked immunosorbent assay. The effects of siADAM15 on cell invasion and migration in FLS were also assessed in vitro. The therapeutic effects and side effects of ADAM15 in a rat model of collagen‑induced arthritis (CIA) were examined in vivo. The present results revealed that ADAM15 expression was significantly elevated at the mRNA and protein level in FLSs stimulated with LPS and that silencing ADAM15 suppressed the expression of pro‑inflammatory cytokines and chemokines, preventing FLS cell migration and invasion via inhibiting vascular endothelial growth factor‑A, matrix metalloproteinase (MMP)1 and MMP‑3 expression. In addition, treatment of CIA rats using siADAM15 significantly reduced the arthritis score and extent of joint damage in the rats. These findings indicated that silencing ADAM15 had anti‑inflammatory effects in FLSs and efficiently inhibited the development of CIA. Therefore, ADAM15 may be a potential target molecule for RA therapies.

View Figures

View References

1	Feldmann M, Brennan FM and Maini RN: Rheumatoid arthritis. Cell. 85:307–310. 1996. View Article : Google Scholar : PubMed/NCBI
2	Brennan FM and McInnes IB: Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 118:3537–3545. 2008. View Article : Google Scholar : PubMed/NCBI
3	Ritchlin C: Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res. 2:356–360. 2000. View Article : Google Scholar : PubMed/NCBI
4	Buchan G, Barrett K, Turner M, Chantry D, Maini RN and Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol. 73:449–455. 1988.PubMed/NCBI
5	Gabay C, Lamacchia C and Palmer G: IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 6:232–241. 2010. View Article : Google Scholar : PubMed/NCBI
6	Choy EH and Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
7	Nanki T, Hayashida K, El-Gabalawy HS, et al: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4⁺ T cell accumulation in rheumatoid arthritis synovium. J Immunol. 165:6590–6598. 2000. View Article : Google Scholar : PubMed/NCBI
8	Scott DL: Biologics-based therapy for the treatment of rheumatoid arthritis. Clin Pharmacol Ther. 91:30–43. 2012. View Article : Google Scholar
9	Pruessmeyer J and Ludwig A: The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol. 20:164–174. 2009. View Article : Google Scholar
10	Baren JP, Stewart GD, Stokes A, et al: mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma. Br J Cancer. 107:143–149. 2012. View Article : Google Scholar : PubMed/NCBI
11	Kuefer R, Day KC, Kleer CG, et al: ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. Neoplasia. 8:319–329. 2006. View Article : Google Scholar : PubMed/NCBI
12	Lucas N and Day ML: The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression. J Cell Biochem. 106:967–974. 2009. View Article : Google Scholar : PubMed/NCBI
13	Böhm BB, Aigner T, Gehrsitz A, Blobel CP, Kalden JR and Burkhardt H: Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage. Arthritis Rheum. 42:1946–1950. 1999. View Article : Google Scholar : PubMed/NCBI
14	Böhm BB, Schirner A and Burkhardt H: ADAM15 modulates outside-in signalling in chondrocyte-matrix interactions. J Cell Mol Med. 13:2634–2644. 2009. View Article : Google Scholar
15	Böhm BB, Aigner T, Roy B, Brodie TA, Blobel CP and Burkhardt H: Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling. Arthritis Rheum. 52:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
16	Charrier-Hisamuddin L, Laboisse CL and Merlin D: ADAM-15: a metalloprotease that mediates inflammation. FASEB J. 22:641–653. 2008. View Article : Google Scholar
17	Komiya K, Enomoto H, Inoki I, et al: Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther. 7:R1158–R1173. 2005. View Article : Google Scholar : PubMed/NCBI
18	Böhm BB, Aigner T, Blobel CP, Kalden JR and Burkhardt H: Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue. Arthritis Rheum. 44:2046–2054. 2001. View Article : Google Scholar : PubMed/NCBI
19	Böhm BB, Freund I, Krause K, Kinne RW and Burkhardt H: ADAM15 adds to apoptosis resistance of synovial fibroblasts by modulating focal adhesion kinase signaling. Arthritis Rheum. 65:2826–2834. 2013. View Article : Google Scholar : PubMed/NCBI
20	Yoshioka Y, Kozawa E, Urakawa H, et al: Suppression of hyaluronan synthesis alleviates inflammatory responses in murine arthritis and in human rheumatoid synovial fibroblasts. Arthritis Rheum. 65:1160–1170. 2013. View Article : Google Scholar : PubMed/NCBI
21	Fried D, Böhm BB, Krause K and Burkhardt H: ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions. J Biol Chem. 287:21214–21223. 2012. View Article : Google Scholar : PubMed/NCBI
22	Minakuchi Y, Takeshita F, Kosaka N, et al: Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32:e1092004. View Article : Google Scholar : PubMed/NCBI
23	Li F, Li X, Kou L, Li Y, Meng F and Ma F: SUMO-conjugating enzyme UBC9 promotes proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation. 37:1134–1141. 2014. View Article : Google Scholar : PubMed/NCBI
24	Tarrant TK, Liu P, Rampersad RR, et al: Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model. Arthritis Rheum. 64:1379–1387. 2012. View Article : Google Scholar
25	Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A and Yoshikawa H: Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum. 48:2670–2681. 2003. View Article : Google Scholar : PubMed/NCBI
26	Chang SK, Gu Z and Brenner MB: Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev. 233:256–266. 2010. View Article : Google Scholar : PubMed/NCBI
27	Afuwape AO, Kiriakidis S and Paleolog EM: The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol. 17:961–972. 2002.PubMed/NCBI
28	Mori T, Miyamoto T, Yoshida H, et al: IL-1beta and TNFalpha-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int Immunol. 23:701–712. 2011. View Article : Google Scholar : PubMed/NCBI
29	Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2:364–371. 2002. View Article : Google Scholar : PubMed/NCBI
30	Ehrenstein MR, Evans JG, Singh A, et al: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 200:277–285. 2004. View Article : Google Scholar : PubMed/NCBI
31	Folgueras AR, Pendas AM, Sanchez LM and Lopez-Otin C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 48:411–424. 2004. View Article : Google Scholar : PubMed/NCBI
32	Okada Y, Gonoji Y, Nakanishi I, Nagase H and Hayakawa T: Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol Incl Mol Pathol. 59:305–312. 1990. View Article : Google Scholar : PubMed/NCBI
33	Ding L, Guo D, Homandberg GA, Buckwalter JA and Martin JA: A single blunt impact on cartilage promotes fibronectin fragmentation and upregulates cartilage degrading stromelysin-1/matrix metalloproteinase-3 in a bovine ex vivo model. J Orthop Res. 32:811–818. 2014. View Article : Google Scholar : PubMed/NCBI